Impact of RBM10 and PD-L1 expression on the prognosis of pathologic N1-N2 epidermal growth factor receptor mutant lung adenocarcinoma.

Isaka, Tetsuya; Miyagi, Yohei; Yokose, Tomoyuki; Saito, Haruhiro; Kasajima, Rika; Watabe, Kozue; Shigeta, Naoko; Kikunishi, Noritake; Shigefuku, Shunsuke; Murakami, Kotaro; Adachi, Hiroyuki; Nagashima, Takuya; Ito, Hiroyuki.

Afiliación

Isaka T; Department of Thoracic Surgery, Kanagawa Cancer Center, Yokohama, Japan.
Miyagi Y; Department of Surgery, Yokohama City University, Yokohama, Japan.
Yokose T; Molecular Pathology and Genetics Division, Kanagawa Cancer Center Research Institute, Yokohama, Japan.
Saito H; Department of Pathology, Kanagawa Cancer Center, Yokohama, Japan.
Kasajima R; Department of Thoracic Oncology, Kanagawa Cancer Center, Yokohama, Japan.
Watabe K; Molecular Pathology and Genetics Division, Kanagawa Cancer Center Research Institute, Yokohama, Japan.
Shigeta N; Department of Thoracic Surgery, Kanagawa Cancer Center, Yokohama, Japan.
Kikunishi N; Department of Thoracic Surgery, Kanagawa Cancer Center, Yokohama, Japan.
Shigefuku S; Department of Thoracic Surgery, Kanagawa Cancer Center, Yokohama, Japan.
Murakami K; Department of Thoracic Surgery, Kanagawa Cancer Center, Yokohama, Japan.
Adachi H; Department of Thoracic Surgery, Kanagawa Cancer Center, Yokohama, Japan.
Nagashima T; Department of Thoracic Surgery, Kanagawa Cancer Center, Yokohama, Japan.
Ito H; Department of Thoracic Surgery, Kanagawa Cancer Center, Yokohama, Japan.

Transl Lung Cancer Res ; 12(10): 2001-2014, 2023 Oct 31.

Article en En | MEDLINE | ID: mdl-38025811

Palabras clave

Epidermal growth factor receptor gene mutation (EGFR-Mt); RNA-binding motif protein 10 (RBM10); overall survival (OS); primary lung adenocarcinoma; programmed death-ligand 1 (PD-L1)

Texto completo: 1 Banco de datos: MEDLINE Idioma: En Año: 2023 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Idioma: En Año: 2023 Tipo del documento: Article